AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 36310089
Drug: Beetroot juice
RxNorm normalized name: tamarind juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beetroot juice with 380 mg of nitrate (BR)
Trial: 37256193
Drug: Saline placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline placebo injection
Trial: 33197676
Drug: Cupping Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cupping Therapy (CT)
Trial: 34928491
Drug: Intranasal ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal ketamine
Trial: 36350082
Drug: Prune treatments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prune treatments (50 g and 100 g)
Trial: 36350082
Drug: Prunes (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prunes (50 g and 100 g)
Trial: 33475255
Drug: JNJ-64565111 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ-64565111 5.0 mg
Trial: 33475255
Drug: JNJ-64565111 7.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ-64565111 7.4 mg
Trial: 33475255
Drug: JNJ-64565111 10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ-64565111 10.0 mg
Trial: 35410294
Drug: Multimodal intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multimodal intervention care (MIC) including ibuprofen, omega‐3‐fatty acid, oral nutritional supplement, weekly physical, psychiatric assessment, nutritional counseling, and complementary and alternative medicine.
Trial: 33468454
Drug: tDCS added
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: tDCS added to a 2-week camp-based therapy
Trial: 33468454
Drug: Camp-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Camp-based therapy alone
Trial: 32343308
Drug: 1 μg/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 μg/ml of sufentanil plus 2.5 μg/ml of DEX (Group D)
Trial: 32343308
Drug: 1 μg/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 μg/ml of sufentanil (Group S)
Trial: 39248270
Drug: Placebo capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsule
Trial: 33855207
Drug: Combined use
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined use of metformin, SGLT2 inhibitor, GLP1 receptor agonist, and basal insulin (step-down approach)
Trial: 37857620
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg ketamine
Trial: 35107563
Drug: Isoproterenol 0.5
RxNorm normalized name: isoproterenol 0.5% inhalation solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoproterenol 0.5 μg
Trial: 32557643
Drug: Therapeutic monoclonal
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic monoclonal antibodies (mAbs)
Trial: 32557643
Drug: Single-dose pharmacokinetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose pharmacokinetic model
Trial: 34759549
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural block with 0.75 mL.kg ‐1 of 0.25% bupivacaine and 1 mcg.kg ‐1 of dexmedetomidine
Trial: 33570787
Drug: 8 mm
RxNorm normalized name: potassium 8 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mm implants + OSFE (Group 2)
Trial: 33570787
Drug: 10 mm
RxNorm normalized name: potassium 10 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mm implants + OSFE (Group 3)
Trial: 33570787
Drug: 6 mm
RxNorm normalized name: I-Port, 6 mm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mm implants (Group 1)
Trial: 36107590
Drug: Midazolam (0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.07 mg/kg)
Trial: 34535520
Drug: Non-opioid pain
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-opioid pain medications
Trial: 35764103
Drug: Balanced salt
RxNorm normalized name: Balanced Salt Solution
DrugBank: Magnesium chloride (DB09407)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Balanced salt solution (BSS) (Group B)
Trial: 35484990
Drug: CDP‐choline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDP‐choline (5 mg/kg in 0.1 mL/kg 0.9% saline, IV; n=9)
Trial: 35484990
Drug: Vehicle (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle (0.1 mL/kg sterile 0.9% saline, IV; n=8)
Trial: 35803302
Drug: Ventilatory strategy
RxNorm normalized name: VENTILATOR FILTER,THERMOFLO #6000S
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ventilatory strategy to prevent atelectasis (VESPA) with endotracheal intubation, recruitment maneuver, FIO2 titration (< 100%), and PEEP of 8 to 10 cm H2O.
Trial: 33629258
Drug: Propranolol (beta-adrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (beta-adrenergic receptor antagonist)
Trial: 36184697
Drug: Mepolizumab 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepolizumab 24 mg
Trial: 36184697
Drug: Reslizumab 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reslizumab 0.8 mg/kg
Trial: 32276071
Drug: 0.6 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 g/kg alcohol intake
Trial: 34934126
Drug: Insulin Resistance
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin Resistance (IR)
Trial: 33788436
Drug: Acupuncture (lifting‐thrusting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture (lifting‐thrusting reinforcing and uniform reducing‐reinforcing methods) applied to specific acupuncture points for 20 min once daily for 3 months.
Trial: 33788436
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group taking Tripterygium Wilfordii Polyglycoside tablets (one tablet per time, 3 times a day) for 3 months.
Trial: 33788436
Drug: Acupuncture group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture group vs Medication group
Trial: 33213125
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement containing 120 mg HA, 240 mg CS, and 300 mg K once a day for 4 weeks
Trial: 33783257
Drug: Trauma‐Focused Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trauma‐Focused Cognitive Behavioral Therapy (TF‐CBT)
Trial: 34210340
Drug: Budesonide/glycopyrrolate/formoterol fumarate
RxNorm normalized name: budesonide/glycopyrrolate/formoterol fumarate 160 mcg-9 mcg-4.8 mcg/actuation INHALATION HFA AEROSOL WITH ADAPTER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/glycopyrrolate/formoterol fumarate (BGF) 320/18/9.6 μg
Trial: 34210340
Drug: Glycopyrrolate/formoterol fumarate
RxNorm normalized name: glycopyrrolate/formoterol fumarate 9/4.8 MCG/INHAL Metered Dose Inhaler, 120 Actuations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate/formoterol fumarate (GFF) 18/9.6 μg
Trial: 36121651
Drug: Nivolumab plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab plus chemotherapy (360 mg Q3W or 240 mg Q2W plus XELOX or FOLFOX)
Trial: 32798723
Drug: Saline alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline alone (1000 mL)
Trial: 35915267
Drug: NARC-15 tablets
RxNorm normalized name: Immunoglobulin g4-kappa, anti-(homo sapienspcsk9 (proprotein convertase subtilisin/kexin type 9, neural apoptosis-regulated convertase 1, narc1, narc-1, proprotein convertase 9, pc9)), humanized monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NARC-15 tablets oxycodone-acetaminophen 5/325 mg (A-OXY)
Trial: 34968756
Drug: Brolucizumab 6
RxNorm normalized name: BROLUCIZUMAB 6 mg in 0.05 mL INTRAVITREAL INJECTION, SOLUTION [BEOVU]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brolucizumab 6 mg
Trial: 34534172
Drug: Dexmedetomidine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1.5 ng/ml; n=40)
Trial: 34534172
Drug: S-ketamine (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-ketamine (0.75 μg/ml; n=20)
Trial: 38604213
Drug: Optimal medical
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal medical therapy
Trial: 35364051
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline injection
Trial: 37625518
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg acetaminophen
Trial: 36093647
Drug: 100 mg/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/L CS‐OL‐NPs
Trial: 36093647
Drug: 5% glutaraldehyde
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glutaraldehyde solution (GA)
Trial: 36093647
Drug: 1 mg/ml
RxNorm normalized name: urea 1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/ml chitosan (CS)
Trial: 33051045
Drug: Anthocyanin supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthocyanin supplementation (125 mg, three times a day)
Trial: 35227790
Drug: Conventional 3-dimensional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional 3-dimensional conformal radiation therapy (CR)
Trial: 32354952
Drug: 24% oral
RxNorm normalized name: Entero VU, 24% oral suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24% oral sucrose solution (0.8 ml/kg)
Trial: 34216034
Drug: tDCS targeting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tDCS targeting L-DLPFC and SM1 simultaneously
Trial: 34836350
Drug: Fructose (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructose (1 g/kg BM)
Trial: 36014763
Drug: Sucralose (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucralose (0.2 g in 300 mL)
Trial: 35488261
Drug: Steroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid therapy
Trial: 39570583
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (ACT)
Trial: 32442136
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of smartphones and tablets
Trial: 32442136
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of smartphones and tablets among caregivers
Trial: 39769201
Drug: Conventional treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatments
Trial: 35182213
Drug: Ultrasound-guided bilateral
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided bilateral TAPB with 40 ml of 0.375% ropivacaine
Trial: 32502267
Drug: Rivaroxaban 15
RxNorm normalized name: rivaroxaban 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 15 mg twice daily
Trial: 36057884
Drug: Palmitoylethanolamide (PEA)
RxNorm normalized name: Palmitoylethanolamide
DrugBank: Palmidrol (DB14043)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palmitoylethanolamide (PEA) 600 mg daily for 8 weeks
Trial: 36143215
Drug: Problem-Solving Treatment
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-Solving Treatment (PST) for 8 weeks
Trial: 34008842
Drug: 900 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 µg vitamin D3
Trial: 34008842
Drug: 900 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 µg 25(OH)D3
Trial: 37891616
Drug: Oral ciprofloxacin
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ciprofloxacin
Trial: 33719606
Drug: Corticosteroid injections
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injections after ultrasound-guided percutaneous lavage (UGPL)
Trial: 33640982
Drug: Cefixime 400
RxNorm normalized name: cefixime 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime 400 mg orally
Trial: 32162448
Drug: 5% glucose
RxNorm normalized name: Dextrose/Water 5% Oral Solution [ENFAMIL 5% GLUCOSE IN WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glucose solution
Trial: 33370477
Drug: Third-party bone
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third-party bone marrow–derived MSC infusion
Trial: 35393305
Drug: Intermittent fasting
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent fasting (daily time-restricted eating; consuming food for not more than 8 hours/day, fasting for at least 16 hours/day)
Trial: 37811711
Drug: Antidepressants
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants
Trial: 32538010
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at lower-he acupoints and front-mu acupoints combined with Tongxieyaofang (TXYF), oral administration of TXYF three times a day, routine acupuncture once a day for four weeks.
Trial: 32538010
Drug: TXYF, oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TXYF, oral administration of TXYF three times a day for four weeks.
Trial: 32538010
Drug: Pinaverium bromide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinaverium bromide, 50 mg, oral administration three times a day for four weeks.
Trial: 36757536
Drug: Ramipril 5
RxNorm normalized name: ramipril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 5 mg
Trial: 36255564
Drug: endoscopic +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: endoscopic + β‐blocker
Trial: 35978446
Drug: Fluoxetine (Prozac)
RxNorm normalized name: fluoxetine Oral Capsule [Prozac]
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine (Prozac) for 9 months
Trial: 34180118
Drug: High sodium
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High sodium concentration (HNa, 143 mEq/L)
Trial: 34180118
Drug: Low sodium
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low sodium concentration (LNa, 138 mEq/L)
Trial: 36455284
Drug: Reduced injection
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced injection technique (5 injection sites)
Trial: 36455284
Drug: Standard injection
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard injection technique (20 injection sites)
Trial: 32865374
Drug: Edoxaban 15
RxNorm normalized name: edoxaban 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 15 mg daily
Trial: 33359791
Drug: mAb AR9.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mAb AR9.6 alone or in combination with gemcitabine
Trial: 34297496
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg abelacimab
Trial: 34297496
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg abelacimab
Trial: 34297496
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg abelacimab
Trial: 33984185
Drug: Ceramide-dominant moisturizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceramide-dominant moisturizing cream and cleanser
Trial: 34866567
Drug: Standard-of-practice CBT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-of-practice CBT (CC)
Trial: 33222296
Drug: 4-implants (4-I)
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4-implants (4-I)
Trial: 33222296
Drug: 6-implants (6-I)
RxNorm normalized name: LEVONORGESTREL 36MG/CAP X 6 IMPLANT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-implants (6-I)
Trial: 36354206
Drug: Propofol-based total
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol-based total intravenous anesthesia (2.0-3.0 mg/kg/h)
Trial: 39038404
Drug: Propofol-based total
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol-based total intravenous anesthesia
Trial: 33877728
Drug: Melatonin 10
RxNorm normalized name: melatonin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 10 mg/day for 12 weeks
Trial: 37164465
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg once daily)
Trial: 35296793
Drug: Intradialytic parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradialytic parenteral nutrition (IDPN) for 3 months
Trial: 35553187
Drug: ebselen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ebselen (10 mg/kg i.p.)
Trial: 35931132
Drug: Pentalong® 50mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentalong® 50mg (PETN) twice daily
Trial: 33751203
Drug: Erector spinae
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erector spinae plane (ESP) block with 20 mL of 0.25% bupivacaine
Trial: 33751203
Drug: Sham block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham block with 20 mL normal saline (Control)
Trial: 32040781
Drug: Focal therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal therapy for localized prostate cancer
Trial: 34328675
Drug: Intervention designed
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intervention designed to reduce concerns during the antenatal anomaly screening process (specific details on dosage and duration are not available).
Trial: 33216782
Drug: Inhalation with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation with 100 mg of 2% lidocaine and 1mg of budesonide
Trial: 32388918
Drug: Candesartan 8
RxNorm normalized name: candesartan 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 8 mg monotherapy
Trial: 32388918
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg monotherapy
Trial: 32388918
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg monotherapy
Trial: 32388918
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Candesartan, Amlodipine, and Atorvastatin
Trial: 39305459
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment
Trial: 34886746
Drug: Castor oil
RxNorm normalized name: Castor Oil
DrugBank: Castor oil (DB11113)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Castor oil (60 mL)
Trial: 37967228
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy for insomnia
Trial: 34225753
Drug: Biologic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biologic therapy (IL‐1 or IL‐6 inhibition)
Trial: 34225753
Drug: Non-biologic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-biologic therapy
Trial: 36142938
Drug: 1 fingertip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 fingertip unit (FTU) of EMLA® with microneedle patch for 30 min before cannulation
Trial: 36142938
Drug: 0.5 FTU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 FTU of EMLA® with microneedle patch for 30 min
Trial: 39054763
Drug: Treatment-As-Usual (TAU)
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-As-Usual (TAU)
Trial: 35339396
Drug: Herbal formula
RxNorm normalized name: Osteo Bi-Flex Joint Health Herbal Formula With Turmeric Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal formula of Foeniculum vulgare and Rosa damascena (10 g, two times a day for 4 weeks)
Trial: 32934722
Drug: TPF induction
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPF induction chemotherapy
Trial: 32227501
Drug: 30 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g/day dried Ziziphus vulgaris for 12 weeks
Trial: 35799088
Drug: Quintile of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quintile of patients with highest average heparin concentration (≥ 4.0 mg⋅kg‐1)
Trial: 32598470
Drug: Generic antidepressants
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic antidepressants (sertraline, paroxetine, escitalopram, venlafaxine, mirtazapine, bupropion)
Trial: 35369705
Drug: Vupanorsen (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vupanorsen (various doses)
Trial: 34218802
Drug: Levofloxacin concomitant
RxNorm normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin concomitant regimen (levofloxacin 500 mg daily, tinidazole 500 mg, amoxicillin 1000 mg, and esomeprazole 20 mg each twice per day for two weeks)
Trial: 36472884
Drug: L-carnitine
RxNorm normalized name: L-Carnitine
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-carnitine
Trial: 34602338
Drug: Maternal voice
RxNorm normalized name: undecylenate
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maternal voice intervention (voice recordings of the mother reading a children's book played during heel stick procedure once daily for 3 consecutive days)
Trial: 34320709
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy (ACTx)